Conquering Diseases

A Study Of Patients With Her2 Positive Breast Cancer Who Have Already Received Treatment


Seeking adult men and women with HER2 positive breast cancer who have already received treatment to determine if a combination of different drugs is better than the usual treatment alone in preventing this cancer from returning.


This study seeks to determine if the combination of T-DM1 and a newer drug tucatinib is better than usual treatment with T-DM1 alone at preventing HER2 positive breast cancer from returning.

What we're hoping for

We want to find out if the approach of this study is better or worse than the usual approach most people get for their breast cancer.

Additional Information Identifier: NCT04457596

 Principal Investigator

Madhavi  Toke, MD

UMass Memorial Health Care

 Study Contact

The Cancer  Research Office



UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655